O(6)-methylguanine-DNA methyltransferase (MGMT) promoter ME has been demonstrated to be associated with increased occurrence of p53 mutation including the G:C→A:T transition and other p53 mutation patterns in lung cancer, especially among nonsmokers (Liu et al., 2006; Wu et al., 2008). Here, TP53 is linked to lung cancer.